GRANULES - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.8
| Stock Code | GRANULES | Market Cap | 14,217 Cr. | Current Price | 586 ₹ | High / Low | 627 ₹ |
| Stock P/E | 37.1 | Book Value | 146 ₹ | Dividend Yield | 0.26 % | ROCE | 10.9 % |
| ROE | 9.14 % | Face Value | 1.00 ₹ | DMA 50 | 577 ₹ | DMA 200 | 553 ₹ |
| Chg in FII Hold | -0.30 % | Chg in DII Hold | 0.60 % | PAT Qtr | 112 Cr. | PAT Prev Qtr | 121 Cr. |
| RSI | 53.8 | MACD | -0.62 | Volume | 10,55,520 | Avg Vol 1Wk | 7,28,032 |
| Low price | 412 ₹ | High price | 627 ₹ | PEG Ratio | -4.31 | Debt to equity | 0.29 |
| 52w Index | 80.6 % | Qtr Profit Var | 23.8 % | EPS | 16.3 ₹ | Industry PE | 27.6 |
📊 Chart & Trend: GRANULES is trading at ₹586, above both its 50 DMA (₹577) and 200 DMA (₹553), reflecting short-term strength. RSI at 53.8 suggests neutral-to-bullish momentum, while MACD (-0.62) indicates mild bearish divergence. Bollinger Bands show price near the mid-zone, signaling consolidation with upward bias.
📈 Momentum Signals: Volume (10.55L) is higher than the 1-week average (7.28L), showing strong participation. RSI above 50 supports bullish momentum, though MACD suggests caution for possible short-term pullbacks.
💡 Entry Zone: ₹570–₹585 (support zone).
🚪 Exit Zone: ₹610–₹625 (resistance). A breakout above ₹627 (recent high) could open room toward ₹650.
📌 Trend Status: The stock is currently consolidating with bullish bias, holding above key moving averages but facing resistance near recent highs.
Positive
- Price trading above both 50 DMA and 200 DMA indicates strength.
- Quarterly PAT of ₹112 Cr, though slightly lower sequentially, remains solid.
- DII holdings increased (+0.60%), signaling domestic institutional support.
- 52-week index gain of 80.6% highlights strong investor confidence.
Limitation
- Stock P/E (37.1) is higher than industry PE (27.6), suggesting premium valuation.
- ROCE (10.9%) and ROE (9.14%) are moderate compared to sector leaders.
- PEG ratio (-4.31) indicates valuation concerns relative to growth.
Company Negative News
- Decline in FII holdings (-0.30%) signals reduced foreign investor confidence.
- Sequential PAT decline (₹112 Cr vs ₹121 Cr) shows earnings pressure.
Company Positive News
- Quarterly profit variation (+23.8%) supports earnings strength year-on-year.
- EPS of ₹16.3 reflects profitability.
- Strong rally from ₹412 to ₹627 highlights momentum strength.
Industry
- Pharmaceutical sector enjoys steady demand and global growth opportunities.
- Industry PE (27.6) is lower than GRANULES’ P/E, suggesting premium valuation.
- Peers trade at moderate valuations, positioning GRANULES as a momentum-driven play.
Conclusion
⚖️ GRANULES is consolidating with bullish bias, supported by price above DMAs and RSI above 50. Fundamentals show strong investor confidence and institutional support, but valuation concerns and moderate ROCE/ROE remain. Entry near ₹570–₹585 offers a margin of safety, with exits around ₹610–₹625. Long-term investors may hold for sector strength, while traders should watch for a breakout above ₹627 for momentum trades.
Selva, would you like me to extend this into a peer benchmarking overlay against pharma players like Divi’s Lab, Aurobindo Pharma, and Dr. Reddy’s? That would highlight relative strength and rotation opportunities alongside GRANULES.